Search results
Down 13% in 4 Weeks, Here's Why Global Partners (GLP) Looks Ripe for a Turnaround
Global Partners LP (GLP) has been on a downward spiral lately with significant selling pressure. After declining 13% over the past four weeks, the stock looks well positioned for a trend reversal as
Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Acumen Pharmaceuticals, Inc. (ABOS) has been on a downward spiral lately with significant selling pressure. After declining 33.6% over the past four weeks, the stock looks well positioned for a
DD Expands Rural Water Infrastructure in Kenya Project With ChildFund
DuPont de Nemours Inc. DD is advancing access to safe drinking water in Kenya by deploying its membrane-based treatment solutions in Baringo County, specifically in the remote community of Kampi ya
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
AbbVie ABBV has built a significant presence in the oncology space. While the majority of the revenues are generated from blood cancer drugs Imbruvica and Venclexta, the company has diversified its
Is Nike (NKE) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Global sportswear leader Nike is set to report its fiscal third-quarter earnings results on Tuesday after the closing bell. A Zacks Rank #3 (Hold), Nike has surpassed the earnings mark in each of
3 Beauty Stocks to Watch as Innovation and Premiumization Fuel Growth
An updated edition of the Feb. 20, 2026, article.The beauty and cosmetics industry continues to stand out as a relatively stable corner of the broader consumer product space, offering a mix of
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY). But which of these two stocks is more attractive to value
Block's Cash App Diversification: Can It Boost Growth?
Block’s XYZ Cash App is a consumer-focused digital wallet enabling peer-to-peer payments, spending and investing. The platform offers the Cash App Card, a Visa debit card linked to user balances and
ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset
ANI Pharmaceuticals ANIP is reshaping its growth profile as specialty therapies take a larger share of the mix. Fiscal 2025 results show accelerating momentum in Rare Disease and Brands, led by
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease
ANI Pharmaceuticals ANIP is setting up 2026 as a year where specialty medicines carry more of the weight. Management expects Rare Disease to represent about 60% of 2026 sales, signaling a continued
Are You Looking for a Top Momentum Pick? Why TotalEnergies SE Sponsored ADR (TTE) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Futu Holdings (FUTU) Upgraded to Strong Buy: What Does It Mean for the Stock?
Futu Holdings Limited Sponsored ADR (FUTU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward
USAR vs. TECK: Which Mining Stock Deserves a Spot in Your Portfolio?
USA Rare Earth, Inc. USAR and Teck Resources Limited TECK are both major players operating in the Zacks Mining - Miscellaneous industry. As peers, each company is engaged in the extraction and
Oil ETFs Steal Spotlight as WTI Tops $100 for First Time in 3 Years
The recent escalation of geopolitical tensions in the Middle East has finally pushed crude oil back into triple-digit territory, with West Texas Intermediate (WTI) crude oil settling above the $100
4 Small Cap Stocks with Outstanding Fundamentals and Momentum
Markets are currently being driven by a mix of competing macro catalysts, from skepticism around AI spending to escalating geopolitical tensions in the Middle East and growing stress in private
Novo Nordisk Aktie: Strategischer Preisangriff
Im wachstumsstarken Markt für Abnehmspritzen ändert Novo Nordisk die Spielregeln. Statt auf simple Preissenkungen…
Der Beitrag Novo Nordisk Aktie: Strategischer Preisangriff erschien zuerst auf kapi
Earnings Season Looms: Why It Matters
Imagine that, once every few months, you must release information detailing your current financial standing. The public can see where you’ve spent money, made money, or even how much you’ve saved.




